Essential Insights into EU GMP Annex 1: 2022 Environmental Monitoring Updates
The Annex 1 update reflects a global shift towards a holistic contamination control approach.
Aligning with Global Standards
You will need to proactively manage risks rather than react to compliance. Aligning closely with World Health Organization (WHO), Pharmaceutical Inspection Cooperation Scheme (PIC/S), and FDA guidelines, the amends distinguish facility qualification from routine monitoring and enhance descriptions of Environmental Monitoring integrated with QRM principles.
Continuous Improvement in 2025 and Beyond
Strengthen operational resilience and product integrity with continual improvement. The expectations are for pharmaceutical manufacturers to go beyond baseline compliance. In fact, you should use the updates as a roadmap for embedding continuous improvement and innovation into your contamination control strategies.
Related Products
Still have questions?
Our customer support is ready to answer your questions or get a quote ready for you.
Resources
-
Environmental Monitoring Best Practices Handbook
-
Cleanroom Compliance Quick-Reference Cards
-
Microbial Control and Monitoring in Aseptic Processing Cleanrooms
-
Quality by Design and Single-Use Air Sampling Approaches
-
Annex 1 2022 v. Annex 1 2008
-
Review of Annex 1: 2022
-
Risk Assessments as a Process Quality Assurance Tool
-
Effective Risk Assessment in Pharmaceutical Manufacturing: Steps to Ensure a Successful Audit
-
Aseptic Environment Monitoring: Manage Your Risk
Contamination Monitoring Solutions
Find Product by Industry
Discover comprehensive contamination control that meets your unique industry requirements.
Find Product by Type
Get the perfect type of contamination monitoring system for your needs.